MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,590
-90 (-0.66%)
Sep 18, 2025, 3:30 PM KST
-0.66%
Market Cap466.47B
Revenue (ttm)72.17B
Net Income (ttm)-99.09B
Shares Out34.10M
EPS (ttm)-2,906.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume82,980
Average Volume168,280
Open13,650
Previous Close13,680
Day's Range13,350 - 13,820
52-Week Range5,580 - 15,180
Beta0.49
RSI67.09
Earnings DateNov 13, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 322
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.